Literature DB >> 27312951

HIF-1α and PPARγ during physiological cardiac hypertrophy induced by pregnancy: Transcriptional activities and effects on target genes.

José G Soñanez-Organis1, José A Godoy-Lugo2, Magally L E Hernández-Palomares2, Daniel Rodríguez-Martínez2, Jesús A Rosas-Rodríguez2, Guadalupe González-Ochoa2, Adolfo Virgen-Ortiz3, Rudy M Ortiz4.   

Abstract

Hypoxia inducible factor 1-α (HIF-1α) and peroxisome proliferator-activated receptor γ (PPARγ) are transcription factors that activate genes involved in cellular metabolism. Physiological cardiac hypertrophy induced by pregnancy initiates compensatory changes in metabolism. However, the contributions of HIF-1α and PPARγ to this physiological status and to its reversible, metabolic process (postpartum) in the heart are not well-defined. Therefore, the aim of the present study was to evaluate the transcriptional activities of HIF-1α and PPARγ in the left ventricle of rats before, during, and after pregnancy. Furthermore, the effects of pregnancy on target genes of glycolysis and glycerol-lipid biosynthesis, key regulatory enzymes, and metabolic intermediates were evaluated. The activities of HIF-1α and PPARγ increased 1.2- and 1.6-fold, respectively, during pregnancy, and decreased to basal levels during postpartum. Expressions of mRNA for glucose transport 1 (GLUT1), enzymes of glycolysis (HK2, PFKM, and GAPDH) and glycerol-lipid biosynthesis (GPAT and GPD1) increased 1.6- to 14-fold during pregnancy and returned to basal levels postpartum. The increase in GPD1 expression translated to an increase in its activity, but such was not the case for GAPDH suggesting that post-translational regulation of these proteins is differential during pregnancy. Glycolytic (glucose, lactate, and DHAP) and glycerol-lipid biosynthesis (G3P and FFA) intermediates increased with pregnancy and were maintained postpartum. The results demonstrate that pregnancy-induced, physiological cardiac hypertrophy activates the expression of genes involved in glycolytic and glycerol-lipid biosynthesis suggesting that the shift in cardiac metabolism is mediated by the activation of HIF-1α and PPARγ.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glycerol; Glycolysis; Lipids; Metabolism; Postpartum

Mesh:

Substances:

Year:  2016        PMID: 27312951     DOI: 10.1016/j.gene.2016.06.025

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

1.  Metabolic signatures of pregnancy-induced cardiac growth.

Authors:  Kyle L Fulghum; Juliette B Smith; Julia Chariker; Lauren F Garrett; Kenneth R Brittian; Pawel K Lorkiewicz; Lindsey A McNally; Shizuka Uchida; Steven P Jones; Bradford G Hill; Helen E Collins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-05-27       Impact factor: 5.125

2.  LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma.

Authors:  Ting-Ting Cai; Shu-Biao Ye; Yi-Na Liu; Jia He; Qiu-Yan Chen; Hai-Qiang Mai; Chuan-Xia Zhang; Jun Cui; Xiao-Shi Zhang; Pierre Busson; Yi-Xin Zeng; Jiang Li
Journal:  PLoS Pathog       Date:  2017-07-21       Impact factor: 6.823

3.  MiR-1 suppresses tumor cell proliferation in colorectal cancer by inhibition of Smad3-mediated tumor glycolysis.

Authors:  Wanfu Xu; Zijing Zhang; Kejian Zou; Yang Cheng; Min Yang; Huan Chen; Hongli Wang; Junhong Zhao; Peiyu Chen; Liying He; Xinwen Chen; Lanlan Geng; Sitang Gong
Journal:  Cell Death Dis       Date:  2017-05-04       Impact factor: 8.469

Review 4.  Metabolic Coordination of Physiological and Pathological Cardiac Remodeling.

Authors:  Andrew A Gibb; Bradford G Hill
Journal:  Circ Res       Date:  2018-06-22       Impact factor: 17.367

5.  Adverse effects of Hif1a mutation and maternal diabetes on the offspring heart.

Authors:  Radka Cerychova; Romana Bohuslavova; Frantisek Papousek; David Sedmera; Pavel Abaffy; Vladimir Benes; Frantisek Kolar; Gabriela Pavlinkova
Journal:  Cardiovasc Diabetol       Date:  2018-05-12       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.